Advances in Epigenetics and Integration of Omics in Lupus

Advances in Epigenetics and Integration of Omics in Lupus

August 1, 2017 at 8:24 AM 0 comments

*Joyce S. Hui-Yuen,1 Suhas K. Ganguli,1 James N. Jarvis2 1. Cohen Children’s Medical Center, Northwell Health and Hofstra-Northwell School of Medicine, New Hyde Park, New York, USA 2. Department of Pediatrics and Genetics, Genomics, & Bioinformatics Program, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USARead More

Nanomedicines for Increased Specificity and Therapeutic Efficacy of Rheumatoid Arthritis

Nanomedicines for Increased Specificity and Therapeutic Efficacy of Rheumatoid Arthritis

August 1, 2017 at 8:23 AM 0 comments

*Bruno Sarmento,1,2 Marco Sarmento3,4 1. Instituto de Investigação e Inovação em Saúde (i3S) and Instituto de Engenharia Biomédica (INEB), Universidade do Porto, Porto, Portugal 2. Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde (CESPU) Instituto Universitário de Ciências da Saúde, Porto, Portugal 3. Faculdade de Medicina Universidade deRead More

Vitamin D Deficiency and Chronic Widespread Pain

Vitamin D Deficiency and Chronic Widespread Pain

August 1, 2017 at 8:22 AM 0 comments

*Ramazan Yilmaz, Serap Ozkayit Department of Physical Medicine and Rehabilitation, Yoncali Physical Medicine and Rehabilitation Hospital, Kutahya, Turkey *Correspondence to drramazanyilmaz@yahoo.com Disclosure: The authors have declared no conflicts of interest. Received: 10.04.17 Accepted: 21.06.17 Citation: EMJ Rheumatol. 2017;4[1]:104-111. Abstract Vitamin D acts as a steroid hormone possessing important functions inRead More

New Drug Treatments for Osteoarthritis: What is on the Horizon?

New Drug Treatments for Osteoarthritis: What is on the Horizon?

March 2, 2017 at 8:24 AM 0 comments

*Fiona E. Watt,1 Malvika Gulati2 1. Arthritis Research UK Centre for Osteoarthritis Pathogenesis, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK 2. Department of Rheumatology, Royal Free Hospital, London, UK *Correspondence to fiona.watt@kennedy.ox.ac.uk Disclosure: The authors have declared no conflicts of interest. Support:Read More

Antiphospholipid Syndrome and the Lungs

Antiphospholipid Syndrome and the Lungs

March 2, 2017 at 8:21 AM 0 comments

*Süreyya Yılmaz,1 Zülfükar Yılmaz2 1. Department of Chest Diseases, Faculty of Medicine, Dicle University, Diyarbakir, Turkey 2. Department of Internal Medicine, Faculty of Medicine, Dicle University, Diyarbakir, Turkey *Correspondence to sureyyayilm@gmail.com Disclosure: The authors have declared no conflicts of interest. Received: 08.02.16 Accepted: 06.06.16 Citation: EMJ. 2017;2[1]:76-82. Abstract Antiphospholipid syndromeRead More

Epigenetic Mechanisms in Sjögren’s Syndrome

Epigenetic Mechanisms in Sjögren’s Syndrome

December 19, 2016 at 4:10 PM 0 comments

Christelle Le Dantec,1 Amandine Charras,1 Anne Bordron,1 Wesley H. Brooks,2 *Yves Renaudineau1,3 1. INSERM ESPRI, ERI29/EA2216, LabEx IGO “Immunotherapy Graft Oncology”, Innovative Medicines Initiative PRECISESADS, Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France 2. Department of Chemistry, University of South Florida, Tampa, Florida, USARead More

The Evolving Landscape of Rheumatology: Biosimilarity and Extrapolation

The Evolving Landscape of Rheumatology: Biosimilarity and Extrapolation

August 26, 2016 at 8:30 AM 0 comments

This symposium took place on 9th June 2016, as part of the European League Against Rheumatism (EULAR) Congress 2016 in London, UK Chairperson: Peter Taylor1 Speakers: Emily Shacter,2 Craig Leonardi,3 Peter Taylor1 1. Kennedy Institute of Rheumatology, Oxford University, Oxford, UK 2. ThinkFDA, LLC, Washington DC, USA 3. Department ofRead More

Introducing New Biosimilars Into Current Treatment Algorithms

Introducing New Biosimilars Into Current Treatment Algorithms

July 26, 2016 at 8:30 AM 0 comments

Summary of a Biogen-sponsored symposium, held at the European League Against Rheumatism (EULAR) Congress 2016 in London, UK, on 9th June 2016 Moderator: John D. Isaacs1 Faculty: Thomas Dörner,2 Tore K. Kvien,3 Arnold Vulto4 1. Institute of Cellular Medicine, Newcastle University, Newcastle, UK 2. Department of Rheumatology and Clinical Immunology,Read More

Optimising Patient Outcomes Throughout the Rheumatoid Arthritis Patient Journey: The Exception, the Standard, and the Rule

Optimising Patient Outcomes Throughout the Rheumatoid Arthritis Patient Journey: The Exception, the Standard, and the Rule

July 26, 2016 at 8:29 AM 0 comments

This satellite symposium took place on 10th June 2016, as a part of the European League Against Rheumatism (EULAR) 17th annual congress in London, UK Chairperson: Peter Taylor1 Speakers: Ronald van Vollenhoven,2 Peter Taylor,1 Daniel Aletaha3 1. University of Oxford, Botnar Research Centre, Oxford, UK 2. Amsterdam Rheumatology and ImmunologyRead More

Unravelling the Mystery Between Structure and Sustained Clinical Outcomes

Unravelling the Mystery Between Structure and Sustained Clinical Outcomes

July 26, 2016 at 8:28 AM 0 comments

This symposium took place on 9th June 2016 as a part of the European League Against Rheumatism (EULAR) Congress 2016 in London, UK Chairperson: Edward Keystone1 Speakers: Edward Keystone,1 Leigh Revers,2 Thomas Dörner,3 1. Toronto General Research Institute, Toronto, Canada 2. University of Toronto, Toronto, Canada 3. Charité – UniversityRead More